Compound Overview

Download

Methotrexate

Entry Curated MiRNA Curated LncRNA Predicted MiRNA Predicted LncRNA
Record 26 0 39 2084

DataTables

Compound ncRNA Type Condition Link
Methotrexate ENSG00000104691.10 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000118412.8 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000131484.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000131484.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000146666.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000152487.6 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000157306.10 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000160336.10 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000163597.10 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000166770.6 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000167117.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000167912.5 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000170919.11 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000171889.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000172250.10 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000172965.10 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000172965.10 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000173867.8 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000173867.8 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000174680.5 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000175061.13 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000175701.6 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000175873.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000177112.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000177133.6 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000177406.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000177410.8 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000177410.8 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000177640.11 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000177640.11 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000178193.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000178412.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000178803.6 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000179743.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000179743.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000179818.9 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000179818.9 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000181798.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000182310.8 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000184274.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000185044.10 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000185168.5 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000185186.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000185186.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000185837.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000185837.3 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000185837.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000185904.7 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000186019.10 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000186594.8 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000186594.8 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000186615.6 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000186615.6 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000187621.10 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000187904.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000188206.5 Predicted lncRNA Sarcoma
Methotrexate ENSG00000188365.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000188825.9 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000189223.9 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000189238.4 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000196295.7 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000196421.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000196559.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000197210.7 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000197813.4 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000197989.9 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000197989.9 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000203279.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000203279.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000203280.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000203288.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000203327.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000203327.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000203362.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000203496.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000203499.6 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000203645.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000203739.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000203801.4 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000203875.6 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000203886.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000204055.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000204791.4 Predicted lncRNA Sarcoma
Methotrexate ENSG00000204802.3 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000204860.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000205037.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000205041.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000205056.8 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000205488.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000205559.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000205622.5 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000205913.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000206140.5 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000206337.6 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000212694.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000213793.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000213971.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000214049.6 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000214105.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000214145.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000214293.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000214293.4 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000214432.5 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000214691.6 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000214725.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000214770.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000214783.5 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000214870.4 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000215022.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000215241.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000215241.3 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000215244.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000215244.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000215304.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000215374.5 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000215417.6 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000215424.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000215424.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000215424.5 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000215483.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000215692.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000215769.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000215841.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000215841.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000217258.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000217576.7 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000218018.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000218510.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000219665.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000220161.4 Predicted lncRNA Sarcoma
Methotrexate ENSG00000221817.5 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000223356.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000223379.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223387.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223396.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223461.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000223462.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223473.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000223482.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000223482.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000223485.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223523.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223528.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000223528.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000223552.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000223571.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000223576.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000223598.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000223608.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223653.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000223665.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223675.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223695.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000223759.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000223764.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000223799.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000223804.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000223811.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000223821.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000223839.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000223842.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000223872.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223882.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000223901.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000223907.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000223975.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224032.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224043.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224043.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224046.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224063.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224079.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224081.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224086.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000224095.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224116.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000224116.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000224138.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000224209.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000224276.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224281.4 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000224356.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000224384.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224429.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000224429.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000224533.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000224541.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224597.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000224635.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224649.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224660.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000224698.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000224699.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224699.4 Predicted lncRNA Sarcoma
Methotrexate ENSG00000224738.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224764.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000224794.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224818.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000224821.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224821.5 Predicted lncRNA Sarcoma
Methotrexate ENSG00000224844.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000224905.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000224934.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000224950.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000224959.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000224969.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000224972.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000224992.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225057.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225083.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000225113.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225146.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000225172.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000225173.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225173.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000225213.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225213.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000225218.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225278.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225285.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000225292.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225298.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225300.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000225302.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000225315.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225328.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225329.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000225383.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225393.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000225408.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000225411.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225411.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000225431.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225439.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225484.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225484.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000225518.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225527.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225527.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000225548.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000225602.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000225667.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000225703.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000225725.4 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000225733.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000225744.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225744.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000225760.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000225791.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000225806.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000225839.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225891.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000225931.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000225938.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000225973.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000225981.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226007.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226007.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000226009.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226026.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226088.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000226113.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226167.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000226200.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226251.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226310.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226312.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000226332.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000226335.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226335.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226367.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000226380.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000226381.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226386.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000226419.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000226453.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000226578.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000226598.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226627.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226649.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000226676.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226688.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226756.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000226853.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226862.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000226876.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000226877.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226891.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226899.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226913.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000226917.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000226950.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000226950.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227014.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227028.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227060.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000227117.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000227165.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227172.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000227186.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227210.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000227210.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227215.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000227218.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000227237.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227245.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227258.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000227356.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227359.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000227372.6 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227398.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227403.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227409.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227479.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227479.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227479.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227492.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000227496.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000227502.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227527.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227540.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227540.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227543.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227589.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000227598.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227627.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227678.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227695.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227698.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227698.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000227719.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000227719.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000227733.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227733.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227885.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000227888.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000227896.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227932.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000227946.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000227946.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227946.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000227954.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227963.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000227963.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000227963.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000228021.3 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000228043.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228084.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228113.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228137.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228140.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000228141.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000228214.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000228251.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228265.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228302.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228363.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228386.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000228393.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228412.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000228481.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000228485.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000228495.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228506.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228554.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000228561.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228604.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228604.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000228614.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228630.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228701.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000228741.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000228748.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000228794.4 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000228852.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000228857.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228865.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228865.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000228886.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228886.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000228889.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000228906.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228956.4 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000228973.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000228989.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000228989.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229122.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229152.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000229178.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000229178.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229321.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229327.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000229373.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229404.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229463.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229463.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229498.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229531.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229587.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000229591.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000229656.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229656.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000229656.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000229660.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229697.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000229739.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000229766.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229771.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000229807.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229839.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229841.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000229848.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000229852.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229869.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229891.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000229915.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229950.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000229953.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000229956.5 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000229970.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000229980.4 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000229980.4 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000229986.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000229999.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230021.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230024.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230051.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230054.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000230058.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000230068.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000230074.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230074.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000230082.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000230082.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000230084.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230102.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000230124.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230140.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230303.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000230368.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000230424.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000230427.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000230454.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000230499.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230526.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230530.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230552.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230606.6 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000230615.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000230615.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000230623.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230658.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230658.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230699.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000230724.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230724.5 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230728.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230735.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230735.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230736.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000230806.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230812.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230825.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230825.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000230834.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000230836.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000230836.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000230844.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000230850.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230880.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000230896.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231010.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000231010.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000231057.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000231119.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000231119.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000231160.5 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000231170.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000231185.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231187.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000231336.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000231346.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000231407.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000231439.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000231473.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231483.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000231521.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000231527.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000231530.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231551.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231607.4 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000231611.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000231616.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231616.4 Predicted lncRNA Sarcoma
Methotrexate ENSG00000231636.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000231646.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000231663.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000231681.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000231691.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000231704.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000231704.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000231713.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000231734.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231742.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000231760.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000231768.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000231851.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000231856.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000231890.3 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000231999.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000231999.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000232019.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232028.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232034.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000232053.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000232065.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000232072.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000232093.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232098.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000232151.5 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000232224.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000232224.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000232274.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232290.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232295.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000232300.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232336.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232412.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000232442.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000232453.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232453.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000232455.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000232480.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000232480.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000232485.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232504.4 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000232504.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000232536.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000232586.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000232593.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232611.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000232642.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000232656.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000232677.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232677.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000232719.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000232732.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232739.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232811.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000232860.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232874.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000232936.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232936.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000232956.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000232956.4 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000232956.4 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000232977.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000233013.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000233016.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000233030.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000233033.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000233033.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000233061.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000233069.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000233080.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000233203.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000233237.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000233237.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000233244.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000233246.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000233330.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000233330.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000233368.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000233387.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000233429.5 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000233452.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000233509.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000233547.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000233593.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000233610.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000233757.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000233797.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000233806.3 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000233825.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000233862.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000233862.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000233906.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000233922.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000233930.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000233937.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000233937.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000234072.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234111.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234134.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234141.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234160.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000234171.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234183.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234185.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234185.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000234210.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234225.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000234263.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234281.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234393.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000234456.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000234456.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234478.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000234509.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234520.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234520.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000234571.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000234584.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000234690.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234690.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234694.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000234740.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234741.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234753.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234753.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000234753.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000234771.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234818.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000234869.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000234871.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000234912.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234915.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000234917.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234936.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234943.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000234978.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235106.4 Predicted lncRNA Sarcoma
Methotrexate ENSG00000235121.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000235204.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000235246.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000235313.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000235373.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235373.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000235381.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235381.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000235387.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235398.4 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000235408.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000235427.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235427.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000235475.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000235501.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000235522.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235545.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000235565.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000235586.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000235635.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235635.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000235659.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235663.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000235770.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235781.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000235802.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000235834.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235852.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000235904.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235910.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000235919.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235919.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000235927.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000235954.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000235989.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000235999.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236066.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000236088.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236098.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236144.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236166.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000236200.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000236200.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236206.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000236242.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000236242.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236308.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236337.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000236434.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236438.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236438.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000236472.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000236494.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236498.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236519.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236519.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236526.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000236528.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000236536.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236558.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236581.4 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000236591.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000236601.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236671.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236740.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236740.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000236859.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000236869.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000236869.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000236869.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000236869.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236896.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000236908.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000236914.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000236936.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000236991.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000237017.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000237017.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237073.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000237094.7 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000237179.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237181.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000237188.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000237248.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000237250.3 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000237291.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000237301.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000237336.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237410.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000237423.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237463.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237499.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000237499.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000237502.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000237502.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237517.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000237520.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237523.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237529.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237531.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000237576.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000237594.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000237595.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237687.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000237714.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237737.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000237773.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237781.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000237805.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237807.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000237813.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237851.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237857.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000237877.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000237886.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000237934.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000237934.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000237937.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000237943.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000237950.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000238005.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000238009.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000238035.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000238035.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000238113.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000238122.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000238133.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000238186.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000238197.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000238197.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000238198.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000238261.5 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000238287.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000239335.4 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000239415.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000239480.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000239508.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000239552.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000239569.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000239569.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000239636.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000239705.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000239774.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000239828.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000239828.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000239828.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000239828.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000239906.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000239906.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000239920.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000239945.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000240006.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000240137.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000240254.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000240254.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000240449.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000240449.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000240549.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000240567.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000240571.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000240571.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000240618.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000240996.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000241155.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000241155.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000241180.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000241288.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000241316.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000241472.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000241481.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000241593.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000241599.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000241764.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000241764.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000241769.3 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000241860.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000242082.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000242104.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000242104.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000242268.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000242288.6 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000242474.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000242474.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000242516.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000242578.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000242781.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000242797.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000242828.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000243176.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000243224.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000243243.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000243368.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000243485.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000243533.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000243885.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000243926.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000243960.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000244063.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000244063.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000244124.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000244128.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000244184.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000244203.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000244268.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000244286.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000244300.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000244393.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000244513.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000244733.4 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000244733.4 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000244968.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000245059.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000245213.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000245248.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000245275.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000245479.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000245526.4 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000245534.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000245534.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000245573.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000245598.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000245662.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000245694.4 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000245711.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000245904.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000245910.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000246130.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000246130.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000246211.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000246263.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000246263.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000246323.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000246323.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000246331.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000246334.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000246422.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000246422.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000246582.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000246640.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000246640.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000246763.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000246859.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000246889.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000246898.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000246985.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247092.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000247134.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247271.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000247345.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000247363.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247373.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247400.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000247595.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247675.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247679.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000247708.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000247809.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000247877.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248092.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000248103.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248112.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000248254.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000248265.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000248265.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000248266.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000248275.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000248360.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000248367.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248367.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000248473.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000248489.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000248508.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248517.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000248538.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000248559.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248559.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000248668.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000248671.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000248724.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248724.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000248724.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000248740.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248787.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000248844.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000248846.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000248925.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000248932.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000248932.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000248994.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249028.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249035.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249094.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249207.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000249249.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000249267.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249328.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000249356.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000249378.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249409.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249417.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000249572.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249592.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249602.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249647.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249655.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000249673.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249734.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000249753.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249786.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000249791.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249825.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000249859.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000249859.3 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000249868.4 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000249898.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250012.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000250027.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000250069.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000250075.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250081.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250107.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250107.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000250129.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000250132.2 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000250132.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000250208.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250222.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250237.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250250.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250286.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000250295.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250303.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250337.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250343.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250365.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250365.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000250404.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250432.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000250451.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000250508.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000250582.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000250596.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000250608.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000250714.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000250764.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250899.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000250899.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000250900.2 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000250948.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000250948.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000250988.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000250999.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000251022.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000251034.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000251138.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000251169.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251169.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000251175.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000251186.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000251194.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000251221.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000251273.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251323.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000251323.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000251361.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000251391.4 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000251391.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251432.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000251432.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251556.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000251580.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000251580.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000251584.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251602.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000251666.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000251675.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000251867.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253106.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253111.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000253125.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253125.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253172.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000253187.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253187.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253263.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253307.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253327.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253327.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253335.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253347.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000253355.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253372.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000253390.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000253392.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253400.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000253408.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000253476.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000253508.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253552.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253559.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253562.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000253582.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253591.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253603.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253671.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253696.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253701.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253716.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000253720.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000253736.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253741.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000253764.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000253764.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000253848.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000253853.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253878.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000253878.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000253898.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000253917.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253917.3 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000253921.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253930.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000253948.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000253948.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000253955.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000253982.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254038.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254042.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254119.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254153.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254154.4 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254164.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254180.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000254204.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000254207.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254207.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000254208.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000254286.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254295.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000254333.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254350.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254353.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254353.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000254369.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254389.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254418.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254419.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254428.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000254461.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254526.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254602.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000254606.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254610.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000254615.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254635.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000254648.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254653.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254670.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254676.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254682.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254703.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254710.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254740.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000254833.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000254855.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000254929.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254960.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000254964.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000254981.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255050.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255050.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255052.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000255081.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255090.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255092.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255094.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255121.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255129.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255129.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255135.3 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255153.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255164.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000255186.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000255197.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255198.3 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255229.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255247.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000255250.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255276.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255320.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255322.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255337.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000255400.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255409.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255409.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255449.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255458.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255478.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255495.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255521.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255542.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255557.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255565.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255717.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255717.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000255741.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000255774.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000255847.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000255857.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000255857.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000255867.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000255867.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000255893.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255946.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000255959.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000256092.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000256196.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000256248.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000256250.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000256268.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000256299.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000256325.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000256433.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000256442.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000256458.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000256546.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000256546.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000256576.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000256690.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000256742.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000256789.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000256824.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000256947.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000256967.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000257023.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257038.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257084.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257135.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000257183.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257222.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000257261.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000257285.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000257354.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000257366.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257391.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257488.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257509.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000257534.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000257543.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257563.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257596.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257605.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257612.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257698.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257698.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257698.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000257702.3 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000257702.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257718.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000257771.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257808.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000257815.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257829.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257831.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257894.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000257900.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000257910.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000257910.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000257913.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000257953.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000257999.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000258001.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258048.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000258057.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258081.3 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258082.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000258101.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000258102.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258137.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000258199.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258199.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000258199.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000258344.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258354.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258354.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000258404.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258428.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000258451.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258479.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000258498.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258558.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258561.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000258661.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000258667.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258689.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000258689.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258701.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000258789.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258798.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000258825.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000258851.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000258858.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000258860.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258919.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258929.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000258952.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000258955.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259005.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259038.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259062.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259116.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259129.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259146.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259187.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259209.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259215.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259242.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000259251.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259287.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000259298.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000259345.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000259377.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000259416.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259418.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259424.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259439.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000259442.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259488.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259542.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000259548.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000259553.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000259563.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259595.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259635.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000259645.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259647.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000259659.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000259687.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000259702.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259709.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000259709.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000259744.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259744.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259758.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000259762.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259792.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000259802.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259802.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000259804.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000259806.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259818.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000259826.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259826.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000259840.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259863.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000259865.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000259877.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259884.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000259943.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000259943.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000259959.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000259994.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260006.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260008.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260017.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260018.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260021.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260022.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260022.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260037.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260037.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260060.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260060.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260065.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260083.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000260086.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260088.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000260118.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260120.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260156.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260193.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260196.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260196.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260219.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260228.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260233.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260236.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260248.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260260.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260261.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260261.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260273.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260289.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260293.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260296.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260296.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000260306.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260310.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260316.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000260316.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000260329.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260352.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260360.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260364.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260378.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260388.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260394.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260400.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260411.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260425.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260430.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260436.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260448.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260464.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260464.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260468.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260509.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260526.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260528.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260578.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260583.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260589.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260589.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260593.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260619.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260625.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000260626.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260633.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000260633.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260637.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000260646.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260648.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260648.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000260671.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260704.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260766.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260787.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260798.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260804.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260805.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260805.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260833.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260834.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260895.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260905.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260910.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260917.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260917.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260920.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260924.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260927.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000260927.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000260927.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000260929.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260931.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000260932.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000260932.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000260941.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000260942.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260948.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000260948.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000260949.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000260954.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000260962.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260963.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000260988.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261002.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000261005.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261008.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261039.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261040.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261057.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261096.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261096.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261101.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261103.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000261124.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261126.3 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261126.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000261135.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261141.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261172.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261173.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261188.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261204.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261204.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000261242.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000261251.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261254.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261280.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261338.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261341.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000261386.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261396.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261399.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261420.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261428.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261431.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000261434.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000261441.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261442.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000261451.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261451.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261468.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261474.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261488.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261526.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261542.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000261542.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261560.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261574.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000261582.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261584.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000261589.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261592.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261613.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000261618.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261644.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261654.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000261663.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261690.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261712.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000261716.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261723.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000261731.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261737.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000261737.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000261737.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000261765.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000261770.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000261775.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261777.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000261801.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000261801.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000261823.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000261824.2 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000261840.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000261840.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000261872.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000262001.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000262115.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000262152.2 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000262171.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000262194.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000262202.3 Predicted lncRNA Sarcoma
Methotrexate ENSG00000262222.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000262223.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000262228.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000262298.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000262332.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000262362.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000262370.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000262412.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000262434.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000262477.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000262514.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000262558.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000262585.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000262686.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000262703.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000262721.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000262766.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000262769.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000262810.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000262879.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000262879.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000262888.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000262903.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000262905.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000263004.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000263033.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000263050.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263069.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000263069.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000263069.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000263072.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263098.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000263120.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000263214.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263272.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000263280.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263280.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000263345.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000263350.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263350.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000263388.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000263400.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000263412.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263429.3 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000263466.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000263470.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000263531.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263627.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000263718.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000263727.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263731.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263731.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000263745.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000263766.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000263786.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263859.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263859.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000263884.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000263924.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000263931.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000264107.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000264107.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000264207.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000264207.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000264247.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000264269.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000264270.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000264290.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000264304.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000264339.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000264365.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000264365.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000264486.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000264520.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000264548.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000264548.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000264575.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000264647.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000264673.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000264860.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000264940.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000264968.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000265055.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000265091.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000265091.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000265206.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000265242.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265242.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000265242.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000265334.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265334.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000265394.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000265399.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000265443.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265443.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000265490.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000265519.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000265688.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000265688.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000265688.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000265692.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265692.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000265692.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000265702.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000265749.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000265750.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000265778.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265791.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000265800.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000265800.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000265908.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000265908.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000266079.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000266289.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000266313.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000266340.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266378.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000266397.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000266402.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000266402.2 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000266411.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000266456.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000266466.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266473.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000266473.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000266578.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000266599.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266601.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266664.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266717.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266801.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266821.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266835.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266844.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000266877.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266893.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266900.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000266903.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266904.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000266912.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000266921.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000266923.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266930.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000266933.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000266969.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000266970.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000266983.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000266983.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000266993.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000267002.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267003.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267015.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267018.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267018.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267040.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267067.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267082.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267100.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267108.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267108.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000267108.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267112.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267141.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000267143.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267159.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267169.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000267174.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267197.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267199.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267207.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267212.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267221.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267232.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267232.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267248.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267251.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267255.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000267255.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267262.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267265.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267272.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000267274.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000267277.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267288.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267302.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000267311.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267316.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267321.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267344.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267347.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000267381.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267394.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267416.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267419.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267446.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267449.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267462.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267475.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267475.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267476.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267481.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267499.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267504.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267504.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267510.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267519.2 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267543.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267546.2 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267567.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267581.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267605.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267651.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000267655.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267655.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000267666.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267672.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267737.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267745.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000267764.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267778.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267787.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267804.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000267834.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267858.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267871.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267898.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000267934.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000267939.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000267940.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000267940.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268006.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268006.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000268015.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268047.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000268047.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000268049.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268066.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000268093.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000268095.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000268164.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000268199.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000268204.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268289.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000268340.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268355.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000268362.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268364.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268392.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268392.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268401.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000268401.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000268458.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000268520.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268520.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000268543.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268568.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000268583.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268605.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000268655.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000268683.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268751.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000268812.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268836.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268836.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000268889.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000268895.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000268912.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000268912.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000268913.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000268945.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000268970.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269038.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269038.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269038.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269066.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269091.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269091.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000269107.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269172.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000269290.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269293.2 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269293.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269386.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269386.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269392.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000269416.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269425.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000269439.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269444.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269444.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269473.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269486.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269486.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000269489.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269535.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269574.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269600.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269609.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269609.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269646.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269696.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269815.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269867.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269893.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269899.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269899.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000269925.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000269927.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269938.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269947.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269947.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269956.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269959.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000269966.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000269966.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000269980.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000269983.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000269989.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000269990.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000269997.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270000.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270006.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270006.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270018.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270022.2 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270022.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270031.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270048.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270049.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270061.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270062.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000270068.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270068.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270069.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000270074.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270081.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270084.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270095.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270102.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270105.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270109.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270109.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270130.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270141.2 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270143.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000270145.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270145.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270157.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000270159.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270168.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000270170.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270170.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000270173.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270173.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270210.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270237.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270302.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270332.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270426.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000270462.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270605.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000270605.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000270641.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270659.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000270681.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000270681.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000270883.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000270949.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000270949.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000270964.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000270988.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271020.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000271119.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271127.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000271133.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271185.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271199.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271199.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271199.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000271218.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271270.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271324.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000271327.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000271335.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271344.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271344.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000271551.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271631.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271643.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000271643.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000271646.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000271659.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271709.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000271734.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000271738.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271743.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271755.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271757.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000271788.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000271788.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271788.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000271815.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271816.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271849.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271851.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271855.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271857.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271874.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000271888.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271894.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271897.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271911.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271912.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000271927.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271948.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000271948.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000271948.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271963.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271964.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271971.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271978.1 Predicted lncRNA Lymphoid neoplasm diffuse large B-cell lymphoma
Methotrexate ENSG00000271983.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271983.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000271996.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000271996.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000271997.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272004.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272004.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272005.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272005.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272029.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272030.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272040.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272068.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272068.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272072.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272076.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272077.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272077.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272077.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272079.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272079.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272079.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272086.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272092.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000272128.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272140.2 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272142.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272143.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272144.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272144.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272144.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272156.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272156.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272172.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272198.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272216.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272221.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272225.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272233.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272235.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272236.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272264.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272275.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272301.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272301.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272308.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272316.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272335.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272335.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272365.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272373.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272379.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272382.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272386.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272417.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272420.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272425.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272440.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272452.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272465.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272482.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272498.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272508.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272518.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272518.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272520.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272523.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272523.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272524.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272524.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000272525.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272564.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272567.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272576.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272576.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272597.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272604.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272635.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272644.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272644.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272645.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272659.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000272659.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272663.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272667.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000272668.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272669.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000272688.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272695.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272696.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272699.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272707.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272716.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272716.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272716.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272721.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272732.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272744.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272744.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272754.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272777.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272777.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272788.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272788.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272788.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000272789.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272792.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272800.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272825.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272828.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272836.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272853.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272853.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272859.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000272861.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000272861.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272870.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272870.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000272885.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272892.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000272892.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000272894.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272904.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272933.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000272945.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000272949.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272953.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272970.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000272983.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000272993.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273004.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273004.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273007.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273011.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273012.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273014.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273015.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000273026.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273056.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273061.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273065.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273071.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273091.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000273129.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273131.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000273133.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273133.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000273142.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273143.1 Predicted lncRNA Liver hepatocellular carcinoma
Methotrexate ENSG00000273162.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273165.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273174.1 Predicted lncRNA Colon adenocarcinoma
Methotrexate ENSG00000273174.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273176.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000273176.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000273188.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273203.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273230.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273245.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273257.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000273265.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273271.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000273289.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000273290.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273306.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273308.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273329.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273335.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273343.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273343.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273350.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273352.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273367.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000273368.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000273374.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273384.1 Predicted lncRNA Sarcoma
Methotrexate ENSG00000273402.1 Predicted lncRNA Breast invasive carcinoma
Methotrexate ENSG00000273428.1 Predicted lncRNA Lung squamous cell carcinoma
Methotrexate ENSG00000273432.1 Predicted lncRNA Pancreatic adenocarcinoma
Methotrexate ENSG00000273449.1 Predicted lncRNA Brain lower grade glioma
Methotrexate ENSG00000273449.1 Predicted lncRNA Chronic Lymphocytic Leukemia
Methotrexate ENSG00000273451.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000273454.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000273456.1 Predicted lncRNA Esophageal cancer
Methotrexate ENSG00000273456.1 Predicted lncRNA Skin cutaneous melanoma
Methotrexate ENSG00000273488.1 Predicted lncRNA Brain lower grade glioma
Methotrexate hsa-miR-103a-3p predicted miRNA NCI60
Methotrexate hsa-miR-1226-5p predicted miRNA NCI60
Methotrexate hsa-miR-125b-5p predicted miRNA NCI60
Methotrexate hsa-miR-127-3p predicted miRNA NCI60
Methotrexate hsa-miR-134 predicted miRNA NCI60
Methotrexate hsa-miR-141-3p predicted miRNA NCI60
Methotrexate hsa-miR-146a-5p predicted miRNA NCI60
Methotrexate hsa-miR-155-5p predicted miRNA NCI60
Methotrexate hsa-miR-181a-5p predicted miRNA NCI60
Methotrexate hsa-miR-181b-5p predicted miRNA NCI60
Methotrexate hsa-miR-181d predicted miRNA NCI60
Methotrexate hsa-miR-192-5p predicted miRNA NCI60
Methotrexate hsa-miR-194-5p predicted miRNA NCI60
Methotrexate hsa-miR-200a-3p predicted miRNA NCI60
Methotrexate hsa-miR-200b-3p predicted miRNA NCI60
Methotrexate hsa-miR-200c-3p predicted miRNA NCI60
Methotrexate hsa-miR-212-3p predicted miRNA NCI60
Methotrexate hsa-miR-215 predicted miRNA NCI60
Methotrexate hsa-miR-362-3p predicted miRNA NCI60
Methotrexate hsa-miR-376a-3p predicted miRNA NCI60
Methotrexate hsa-miR-376c-3p predicted miRNA NCI60
Methotrexate hsa-miR-377-3p predicted miRNA NCI60
Methotrexate hsa-miR-424-5p predicted miRNA NCI60
Methotrexate hsa-miR-429 predicted miRNA NCI60
Methotrexate hsa-miR-432-5p predicted miRNA NCI60
Methotrexate hsa-miR-450a-5p predicted miRNA NCI60
Methotrexate hsa-miR-483-3p predicted miRNA NCI60
Methotrexate hsa-miR-487b predicted miRNA NCI60
Methotrexate hsa-miR-532-5p predicted miRNA NCI60
Methotrexate hsa-miR-542-3p predicted miRNA NCI60
Methotrexate hsa-miR-572 predicted miRNA NCI60
Methotrexate hsa-miR-575 predicted miRNA NCI60
Methotrexate hsa-miR-584-5p predicted miRNA NCI60
Methotrexate hsa-miR-638 predicted miRNA NCI60
Methotrexate hsa-miR-650 predicted miRNA NCI60
Methotrexate hsa-miR-660-5p predicted miRNA NCI60
Methotrexate hsa-miR-770-5p predicted miRNA NCI60
Methotrexate hsa-miR-874 predicted miRNA NCI60
Methotrexate hsa-miR-892b predicted miRNA NCI60
Methotrexate miR-140 Curated miRNA colon cancer
Methotrexate miR-149 Curated miRNA colon cancer
Methotrexate miR-193b Curated miRNA colon cancer
Methotrexate miR-210 Curated miRNA colon cancer
Methotrexate miR-215 Curated miRNA osteosarcoma and colon cancer
Methotrexate miR-224 Curated miRNA colon cancer
Methotrexate miR-24 Curated miRNA fibrosarcoma
Methotrexate miR-27b Curated miRNA colon cancer
Methotrexate miR-320 Curated miRNA colon cancer
Methotrexate miR-34c Curated miRNA osteosarcoma
Methotrexate miR-361 Curated miRNA colon cancer
Methotrexate miR-365 Curated miRNA colon cancer
Methotrexate miR-378 Curated miRNA brain tumour
Methotrexate miR-382 Curated miRNA osteosarcoma
Methotrexate miR-455 Curated miRNA colon cancer
Methotrexate miR-615 Curated miRNA colon cancer